Abstract
To investigate the efficacy and safety of once-daily semaglutide in comparison with once-daily liraglutide and placebo in patients with type 2 diabetes. This 26-week, multicenter, double-blind trial involved patients diagnosed with type 2 diabetes with HbA1c 7.0-10.0% (53-86 mmol/mol) and treated with diet and exercise with or without metformin. Patients were randomized 2:2:1 to once-daily semaglutide, liraglutide, or placebo in one of four volume-matched doses (semaglutide 0.05, 0.1, 0.2, or 0.3 mg and liraglutide 0.3, 0.6, 1.2, or 1.8 mg, with both compared within each volume-matched dose group). Primary end point was change in HbA1c from baseline to week 26. In total, 705 randomized patients were exposed to trial products. At week 26, a dose-dependent change in HbA1c was observed with semaglutide from -1.1% (0.05 mg) to -1.9% (0.3 mg) and with liraglutide from -0.5% (0.3 mg) to -1.3% (1.8 mg) (all P < 0.001 in favor of volume-matched semaglutide dose). Change with pooled placebo was -0.02% (P < 0.0001 vs. semaglutide). Gastrointestinal (GI) disorders were the most common adverse events (AEs) with semaglutide and liraglutide, occurring in 32.8-54.0% and 21.9-41.5% of patients, respectively. Once-daily semaglutide at doses up ...Continue Reading
References
Mar 21, 1998·The Journal of Clinical Investigation·A FlintJ J Holst
Jul 2, 1999·Diabetes Care·M B Toft-NielsenJ J Holst
Apr 26, 2008·Diabetes, Obesity & Metabolism·M HorowitzS Madsbad
Jan 14, 2011·The American Journal of Medicine·Michael A Nauck
Apr 17, 2013·Diabetes Care·Elizabeth R SeaquistRobert Vigersky
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Jan 1, 2014·Progress in Molecular Biology and Translational Science·Prashant NadkarniGeorge G Holz
Sep 10, 2014·The Journal of Clinical Investigation·Anna SecherLotte Bjerre Knudsen
Aug 27, 2015·Journal of Medicinal Chemistry·Jesper LauThomas Kruse
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Sep 17, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN SUSTAIN-6 Investigators
Nov 20, 2016·Diabetes, Obesity & Metabolism·Christopher K RaynerMichael Horowitz
Dec 17, 2016·Diabetes Care
Jan 24, 2017·The Lancet. Diabetes & Endocrinology·Christopher SorliStephen C Bain
Mar 28, 2017·The Lancet. Diabetes & Endocrinology·Vanita R ArodaJ Hans DeVries
Apr 8, 2017·The Lancet. Diabetes & Endocrinology·Bo AhrénFrancis Chow
Sep 25, 2017·Diabetes, Obesity & Metabolism·Julie B HjerpstedJohn Blundell
Dec 17, 2017·Diabetes Care·Andrew J AhmannVanita R Aroda
Apr 25, 2018·The Journal of Clinical Endocrinology and Metabolism·Helena W RodbardPaul Norwood
Citations
Jul 27, 2018·Diabetes, Obesity & Metabolism·Rune V OvergaardDesirée Thielke
Aug 14, 2018·Journal of Diabetes Investigation·Bo Ahrén
Feb 16, 2019·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Georgios A ChristouDimitrios N Kiortsis
May 31, 2019·Metabolic Syndrome and Related Disorders·Ajay Sood, Arthur Swislocki
Oct 28, 2019·Diabetes, Obesity & Metabolism·Louis S MatzaLuis-Emilio García-Pérez
Oct 16, 2019·Clinical and Experimental Hypertension : CHE·Di ZhaoPingshuan Dong
May 23, 2020·Obesity·Robert F KushnerDomenica Rubino
May 20, 2020·Expert Opinion on Drug Safety·Rajesh Peter, Steve C Bain
Oct 21, 2019·Hormones : International Journal of Endocrinology and Metabolism·Paschou Sa, Theodoros Alexandrides
Feb 23, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Kenneth Cusi
Apr 30, 2019·Frontiers in Endocrinology·Lotte Bjerre Knudsen, Jesper Lau
Jan 11, 2020·Endocrinology, Diabetes & Metabolism·Sanaz KamaliniaSheldon W Tobe
Apr 1, 2020·Journal of the American Heart Association·Mengdie HuLinong Ji
Feb 4, 2021·Diabetes Care·Sushrima GanEwan R Pearson
Nov 17, 2020·BMC Medicine·Chu LinLinong Ji
Feb 23, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Matthias HepprichGottfried Rudofsky
Mar 24, 2021·JAMA : the Journal of the American Medical Association·Domenica RubinoUNKNOWN STEP 4 Investigators
Jul 23, 2021·The Lancet. Diabetes & Endocrinology·Juan P FríasJohn B Buse
Jul 22, 2021·Seminars in Liver Disease·Sabine KahlMichael Roden
Aug 19, 2021·The Journal of Clinical Endocrinology and Metabolism·Chandani Patel ChavezSushma Kadiyala
Dec 9, 2021·EClinicalMedicine·Kia VosoughiMichael Camilleri
Dec 12, 2021·Clinical Drug Investigation·Feiyu WangPinfang Huang
Feb 5, 2022·Advances in Therapy·Ayman A Al Hayek, Mohamed A Al Dawish